Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)
Found 18 hits in this display
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
IC50: 10nMAssay Description:Inhibition of recombinant SARS-CoV-2 main protease usingDABCYLKTSAVLQSGFRKME(EDANS)-NH2 fluorogenic peptide substrate by FRET assayMore data for this Ligand-Target Pair
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
Prothrombin(Homo sapiens (Human))Shionogi Pharmaceutical Research Center
Curated by ChEMBL
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
Cathepsin G(Homo sapiens (Human))Shionogi Pharmaceutical Research Center
Curated by ChEMBL
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
Cathepsin D(Homo sapiens (Human))Shionogi Pharmaceutical Research Center
Curated by ChEMBL
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
Cathepsin B(Homo sapiens (Human))Shionogi Pharmaceutical Research Center
Curated by ChEMBL
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
Caspase-2(Homo sapiens (Human))Shionogi Pharmaceutical Research Center
Curated by ChEMBL
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
EC50: 370nMAssay Description:Antiviral activity against SARS-CoV-2, SARS-CoV, MERS-CoV and HCoV-229E was assessed by monitoring cell viability; that against HCoV-OC43 was assesse...More data for this Ligand-Target Pair
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
EC50: 210nMAssay Description:Antiviral activity against SARS-CoV-2, SARS-CoV, MERS-CoV and HCoV-229E was assessed by monitoring cell viability; that against HCoV-OC43 was assesse...More data for this Ligand-Target Pair
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
EC50: 74nMAssay Description:Antiviral activity against SARS-CoV-2, SARS-CoV, MERS-CoV and HCoV-229E was assessed by monitoring cell viability; that against HCoV-OC43 was assesse...More data for this Ligand-Target Pair
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
EC50: 5.50E+3nMAssay Description:Antiviral activity against SARS-CoV-2, SARS-CoV, MERS-CoV and HCoV-229E was assessed by monitoring cell viability; that against HCoV-OC43 was assesse...More data for this Ligand-Target Pair
BDBM513874(bioRxiv20220126.477782, S-217622 | bioRxiv20220126...)
EC50: 1.40E+3nMAssay Description:Antiviral activity against SARS-CoV-2, SARS-CoV, MERS-CoV and HCoV-229E was assessed by monitoring cell viability; that against HCoV-OC43 was assesse...More data for this Ligand-Target Pair